In this edition of Cardiovascular News (issue 48), we report on the top stories from TCT 2017—including: ORBITA, CULPRIT-SHOCK and the cost-effectiveness data from PARTNER 2A/SAPIEN 3. We also have commentaries from leading interventional cardiologists, such as Robert Yeh, and profile Justin Davies.
